Iovance Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.About IOVA
Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.
IOVA Key Statistics
Stock Snapshot
With a market cap of 940.81M, Iovance Biotherapeutics(IOVA) trades at $2.35. The stock has a price-to-earnings ratio of -1.96.
During the trading session on 2026-01-14, Iovance Biotherapeutics(IOVA) shares reached a daily high of $2.40 and a low of $2.32. At a current price of $2.35, the stock is +1.3% higher than the low and still -2.1% under the high.
Trading volume for Iovance Biotherapeutics(IOVA) stock has reached 7.58M, versus its average volume of 11.48M.
The stock's 52-week range extends from a low of $1.64 to a high of $6.50.
The stock's 52-week range extends from a low of $1.64 to a high of $6.50.
IOVA News
Iovance Biotherapeutics recently reaffirmed that it expects to meet its earlier 2025 revenue guidance of US$250 million to US$300 million, while reporting that...
Claim 70% Off TipRanks Premium Iovance Biotherapeutics ( (IOVA) ) just unveiled an announcement. On January 9, 2026, Iovance Biotherapeutics updated its corpo...